Talphera (TLPH) Non-Current Debt (2011 - 2023)
Talphera's (TLPH) quarterly Non-Current Debt came in at $3.3 million in Q1 2023, up 8.52% year-on-year from $3.0 million in Q1 2022, and down 38.89% quarter-over-quarter from $5.4 million in Q4 2022.
Talphera (TLPH) Non-Current Debt (2011 - 2023) Analysis & Trends
Talphera's Non-Current Debt history runs 13 years deep, the most recent figure standing at $3.3 million for Q1 2023.
- On a quarterly basis, Non-Current Debt rose 8.52% year-over-year to $3.3 million in Q1 2023; TTM through Mar 2023 was $3.3 million, a 8.52% increase from a year earlier, with the FY2022 full-year figure at $5.4 million, up 7.85% from the prior year.
- Non-Current Debt slipped to $3.3 million in Q1 2023 per TLPH's latest filing, from $5.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $23.8 million in Q2 2019 and bottomed at $3.0 million in Q1 2022.
- The 5-year median for Non-Current Debt is $12.2 million (2020), against an average of $12.5 million.
- Across the five-year window, Non-Current Debt surged 507.01% in 2019 and slumped 73.0% in 2022, its largest moves.
- Year by year, Non-Current Debt stood at $20.5 million in 2019, then sank by 35.96% to $13.1 million in 2020, then tumbled by 61.89% to $5.0 million in 2021, then grew by 7.85% to $5.4 million in 2022, then sank by 38.89% to $3.3 million in 2023.
- Per Business Quant, the three latest TLPH Non-Current Debt figures stand at $3.3 million (Q1 2023), $5.4 million (Q4 2022), and $3.0 million (Q1 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Talphera | 47.31 Mn | 9.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 3.30 Mn |
| Dec 31, 2022 | 5.40 Mn |
| Mar 31, 2022 | 3.04 Mn |
| Dec 31, 2021 | 5.01 Mn |
| Sep 30, 2021 | 6.95 Mn |
| Jun 30, 2021 | 9.37 Mn |
| Mar 31, 2021 | 11.27 Mn |
| Dec 31, 2020 | 13.14 Mn |
| Sep 30, 2020 | 14.99 Mn |
| Jun 30, 2020 | 17.32 Mn |
| Mar 31, 2020 | 19.13 Mn |
| Dec 31, 2019 | 20.52 Mn |
| Sep 30, 2019 | 21.92 Mn |
| Jun 30, 2019 | 23.77 Mn |
| Dec 31, 2018 | 3.38 Mn |
| Sep 30, 2018 | 5.50 Mn |
| Jun 30, 2018 | 7.54 Mn |
| Mar 31, 2018 | 9.49 Mn |
| Dec 31, 2017 | 11.37 Mn |
| Sep 30, 2017 | 13.15 Mn |